Homocarnosine and the measurement of neuronal pH in patients with epilepsy

Magnetic Resonance in Medicine

Volumn 38, Issue 6, 1997, Pages 924-929

  Rothman, Douglas L ^a,b   Behar, Kevin L ^a   Prichard, James W ^a   Petroff, Ognen A C ^a  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epilepsy; Homocarnosine; Human brain; Vigabatrin

Indexed keywords

AMINO ACIDS; CHEMICAL SHIFT; METABOLITES; NEURONS;

EPILEPSY; GAMMA-AMINOBUTYRIC ACIDS; HOMOCARNOSINE; HUMAN BRAIN; INVERSION RECOVERY; PHYSIOLOGICAL CONDITION; TITRATION CURVES; VIGABATRIN;

NEUROLOGY;

HOMOCARNOSINE; PHOSPHATE; PHOSPHOETHANOLAMINE; VIGABATRIN;

ADULT; ARTICLE; CELL PH; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NERVE CELL; NUCLEAR MAGNETIC RESONANCE; OCCIPITAL LOBE;

EID: 0030695043     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910380611     Document Type: Article

References (38)

1. M. Chesler, The regulation and modulation of pH in the nervous system. Progress in Neurobiology 34, 401-427 (1990).
2. B. K. Siosjo, The bicarbonate/carbonic acid buffer system of the cerebral cortex of cats, as studies in tissue homogenates. Acta Neurol. Scand. 38, 121-141 (1962).
3. 31P nuclear magnetic resonance spectroscopy. Neurology 35, 781-788 (1985).
4. 31P magnetic resonance. J. Biol. Chem. 148, 7276-7278 (1973).
5. E. B. Cady, A. M. Costello, M. J. Dawson, D. T. Delpy, P. L. Hope, E. O. R. Reynolds, P. S. Tofts, D. R. Wilkie, Noninvasive investigation of cerebral metabolism in nowborn infants by phosphorus and nuclear magnetic resonance spectroscopy. Lancet ii, 1059-1062 (1983).
6. O. A. C. Petroff, J. W. Prichard, Measurement of cytosolic pH by nuclear magnetic resonance spectroscopy, in "Methods in Neuroscience" (J. Kraicer, S. J. Dixon, Eds.), 27, pp. 233-251, Academic Press, Orlando, 1995.
7. M. C. Jackson, D. M. Scollard, R. J. Mack, J. F. Lenney, Localization of a novel pathway for the liberation of GABA in human CNS. Brain Res. Bull. 33, 379-385 (1994).
8. C. Jakobs, J. Jaeken, K. M. Gibson, Inherited disorders of GABA metabolism. J. Inher. Metab. Dis. 16, 704-715 (1993).
9. L. R. Gjessing, H. A. Lunde, L. Morkrid, J. F. Lenney, O. Sjaastad, Inborn errors of carnosine and homocarnosine metabolism. J. Neural. Transm. 29, 91-106 (1990).
10. S. J. Kish, T. L. Perry, S. Hansen, Regional distribution of homocarnosine, homocarnosine-carnosine synthetase, and homocarnosinase in human brain. J. Neurochem. 32, 1629-1636 (1979).
11. T. L. Perry, S. J. Kish, O. Sjaastad, L. R. Gjessing, R. Nesbakken, H. Schrader, A. C. Løken, Homocarnosinosis: increased content of homocarnosine and deficiency of homocarnosinase in brain. J. Neurochem. 32, 1637-1640 (1979).
12. T. L. Perry, S. Hansen, S. S. Gandham, Postmortem changes of amino compounds in human and rat brain. J. Neurochem. 36, 406-412 (1981).
13. 1H NMR. Biochemistry 85, 7836-7839 (1988).
14. 1H spectroscopic measurements of GABA, glutamate, and glutamine in human brain. Epilepsia 36, 457-464 (1995).
15. O. A. C. Petroff, D. L. Rothman, K. L. Behar, R. H. Mattson, Human brain GABA levels rise following initiation of vigabatrin therapy, but fail to rise further with increasing dose. Neurology 46, 1459-1463 (1996).
16. O. A. C. Petroff, D. L. Rothman, K. L. Behar, R. H. Mattson, Human brain gamma-aminobutyric acid (GABA) levels and seizure control following initiation of vigabatrin therapy. J. Neurochem. 67, 2399-2404 (1996).
17. O. A. C. Petroff, D. L. Rothman, K. L. Behar, T. L. Collins, R. H. Mattson, Human brain GABA levels rise rapidly following initiation of vigabatrin therapy. Neurology 47, 1567-157 (1996).
18. P. J. Schlechter, N. F. L. Hanke, J. Grove, N. Huebert, A. Sjoerdsma, Biochemical and clinical effects of gamma-vinyl-GABA in patients with epilepsy. Neurology 34, 182-186 (1984).
19. E. Ben-Menachem, L. I. Persson, P. J. Schechter, K. D. Haegele, N. Huebert. J. Hardenberg, L. Dahlgren, J. P. Mumford, The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients. Br. J. Clin. Pharmac. 27(Suppl. 1), 79S-85S (1989).
20. P. J. Reikkinen, A. Ylinen, T. Halonen, J. Sivenius, A. Pitkänen, Cerebrospinal fluid GABA and seizure control with vigabatrin. Br, J. Clin. Pharmac. 27(Suppl. 1), 87S-94S (1989).
21. R. Kälviäinen, T. Halonen, A. Pitkänen, P. J. Reikkinen, Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies. J. Neurochem. 60, 1244-1250 (1993).
22. R. Gruetter, Automatic localized in vivo adjustment of all first- and second-order shim coils. Magn. Reson. Med. 29, 804-811 (1993).
23. 1H NMR measurements of GABA levels in human brain in vivo. Proc. Natl. Acad. Sci. (USA) 90, 5662-5666 (1993).
24. 1H NMR spectra of human brain. Magn. Reson. Med. 32, 294-302 (1994).
25. O. A. C. Petroff, L. A. Pleban, D. D. Spencer. Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of epileptic human brain. Magn. Reson. Imaging 13, 1197-1211 (1995).
26. 1H NMR measurements of glutamate in the human brain. Magn. Reson. Med. 25, 94-106 (1992).
27. O. A. C. Petroff, The measurement of pH using nuclear magnetic resonance spectroscopy. Eur. J. Lab. Med. 4, 143-156 (1996).
28. 1H NMR studies. Neurology 35, 1681-1688 (1988).
29. 31P NMR measurement of cerebral lactate, high-energy phosphate levels, and pH in humans during voluntary hyperventilation: associated EEG, capnographic, and Doppler findings. Magn. Reson. Med. 10(2), 182-193 (1989).
30. 31P nuclear magnetic resonance studies of bicuculline-induced seizures in vivo. Ann. Neural. 20, 185-193 (1986).
31. 1H NMR study. Pediatr. Res. 29, 191-195 (1991).
32. 31P magnetic resonance spectroscopic imaging. Neurology 42, 2011-2018 (1992).
33. 31P magnetic resonance spectroscopy of epilepsy, in "Neuroimaging in Epilepsy" (G. D. Cascino, C. R. Jack, Eds.), pp. 145-150, Butterworth-Heinemann, Boston, 1996.
34. 31P nuclear magnetic resonance spectroscopy of human temporal lobe epilepsy. Neurology 42, 1586-1590 (1992).
35. R. J. T. Corbett, A. R. Laptook, R. L. Nunnally, The use of the chemical shift of the phosphomonoester P-31 magnetic resonance peak for the determination of intracellular pH in the brains of neonates. Neurology 37, 1771-1779 (1987).
36. 13C-ethanol in rabbit brain in vivo: a sensitivity comparison. Mogn. Reson. Med. 16, 431-443 (1990).
37. J. J. H. Ackerman, G. E. Soto, W. M. Spees, Z. Zhu, J. L. Evelhoch, The NMR chemical shift pH measurement revisited: analysis of error and modeling of a pH dependent reference. Magn. Reson. Med. 36, 674-683 (1996).
38. 31P NMR spectroscopy: assessment of pH measurement methodology. NMR Biomed. 4, 1-11 (1991).